43
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Epidermal Growth Factor and 17ß-Estradiol Effects on Proliferation of a Human Gastric Cancer Cell Line (AGS)

Pages 753-758 | Published online: 08 Jul 2009

References

  • Wynne GG. The sex ratio in gastric cancer and hypothetical considerations relative to etiology. Br J Cancer 1968;22:164–71.
  • Furukawa H, Iwanaga T, Koyama H, Taniguchi H. Effect of sex hormones on the experimental induction of cancer in rat stomach. A preliminary study. Digestion 1982;23:151–5.
  • Sica V, Nola F, Contieri E, Bova R, Masucci MT, Medici N, et al. Estradiol and progesterone receptors in malignant gastrointestinal tumors. Cancer Res 1984;44:4670–4.
  • Winborn WB, Sheridan PJ, McGill HC Jr. Sex steroid receptors in the stomach, liver, pancreas, and gastrointestinal tract of the baboon. Gastroenterology 1987;92:23–32.
  • Wu CW, Chi CW, Chang TJ, Lui WY, P’eng FK. Sex hormone receptors in gastric cancer. Cancer 1990;65:1396–400.
  • Francavilla A, Di Leo A, Polimeno L, Conte D, Barone M, Fanizza G, et al. Nuclear and cytosolic estrogen receptors in human colon carcinoma and in surrounding non cancerous colonic tissue. Gastroenterology 1987;93:1301–6.
  • Di Leo A, Messa C, Russo F, Misciagna G, Guerra V, Taveri R, et al. Prognostic value of cytosolic estrogen receptors in human colorectal carcinoma and surrounding mucosa. Preliminary results. Dig Dis Sci 1994;9:2038–42.
  • Linsalata M, Messa C, Russo F, Cavallini A, Di Leo A. Estrogen receptors and polyamine levels in human gastric carcinoma. Scand J Gastroenterol 1994;29:67–70.
  • Darbre PD. Steroid and steroid receptors in growth control of cultured breast cancer cells. Int J Cancer 1990;5 Suppl:67–75.
  • Di Leo A, Linsalata M, Cavallini A, Messa C, Russo F. Sex steroid hormone receptors, epidermal growth factor receptor and polyamines in human colorectal cancer. Dis Colon Rectum 1992;35:305–9.
  • Carpenter G, Wahl MI. The epidermal growth factor family. In: Sporn MB, Robert AB, editors. Handbook of experimental pharmacology. Vol. 851. Peptide growth factors and their receptors. Berlin: Springer-Verlag; 1990. p. 69–71.
  • Barnard JA, Beauchamp RD, Russell WE, Dubois RN, Coffey RJ. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 1995; 108:564–80.
  • Yasui W, Sumiyoshi H, Hata J, Kameda T, Ochiai A, Ito I, et al. Expression of epidemal growth factor receptor in human gastric and colonic carcinomas. Cancer Res 1988;48:137–41.
  • Messa C, Russo F, Notarnicola M, Di Leo A. Demonstration of epidermal growth factor receptor in colorectal adenocarcinoma by enzyme immunoassay. Digestion 1994;55:103–7.
  • Polimeno L, Silecchia G, Spaziani E, Scucchi A, Dell’Aquila P, Ierardi E, et al. Estrogen, androgen, and EGF receptor expression in gastric carcinoma induced by N-methyl-N′-nitro-N-nitrosoguanidine. Dig Dis Sci 1994;39:635–40.
  • Messa C, Pricci M, Linsalata M, Russo F, Di Leo A. Inhibitory effect of 17β-estradiol on growth and the polyamine metabolism of human gastric carcinoma cell line (HGC-27). Scand J Gastroenterol 1999;34:79–84.
  • Rajendram KG, Lopez T, Parikh I. Estrogenic effect of phenol red in MCF-7 cells is achieved through activation of estrogen receptor by interacting with a site distinct from the steroid binding site. Biochem Biophys Res Commun 1987;142: 724–31.
  • Coffer AI, Lewis KM, Bockas AJ, King RJB. Monoclonal antibodies against a component related to soluble estrogen receptor. Cancer Res 1985;45:3686–93.
  • Roehm NW, Rodgers GH, Hatfield SM, Glasebrook AL. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt MTT. J Immunol Methods 1991; 142:257–65.
  • Niks M, Otto M. Towards an optimized MTT-assay. J Immunol Methods 1990;130:149–51.
  • Lowry OH, Rosebrough NJ, Farr AL, Randall RS. Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265–7.
  • Phillips HJ. Dye exclusion tests for cell viability. In: Krause PF, Patterson MD, editors. Tissue culture methods and applications. New York: Academic Press; 1973. p. 406–8.
  • Tokunaga A, Onda M, Kiyama T, Nishi K, Mizutani T, Yoshiyuki T, et al. Contrasting actions of estradiol on the growth of human gastric cancer xenografts in nude mice. Jpn J Cancer Res 1989;80:1153–5.
  • Nohga K, Katsumata T, Ishiwata K, Abe O. Experimental and clinical study on chemoendocrine therapy for gastric cancer. J Jpn Surg Soc 1987;88:1109–12.
  • Harrison JD, Watson S, Morris DL. The effect of sex hormone and tamoxifen on the growth of human gastric and colorectal cancer cell lines. Cancer 1989;63:2148–51.
  • Furukawa H, Iwanaga T, Koyama H, Taniguchi H. Effect of sex hormone on carcinogenesis in the stomach of rats. Cancer Res 1982;42:5181–2.
  • Nash JD, Ozols RF, Smyth JF, Hamilton TC. Estrogen and antiestrogen effects on the growth of human epithelial ovarian cancer in vitro. Obstet Gynecol 1989;73:1009–16.
  • Pegg AE, McCann PP. Polyamine metabolism and function. Am J Physiol 1982;243:C212–21.
  • Seiler N. Polyamine metabolism. Digestion 1990;46 Suppl 2:319–30.
  • Piontek M, Hengels K-J, Porschen R, Strohmeyer G. Antiproliferative effect of tyrosine kinase inhibitors in epidermal growth factor-stimulated growth of human gastric cancer cells. Anticancer Res 1993;13:2119–24.
  • Naef M, Yokoyama M, Friess HW, Buchler M, Korc M. Coexpression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma. Int J Cancer 1996;66:315–21.
  • Katzenellenbogen BS. Estrogen receptors: bioactivities and interactions with cell signaling pathways. Biol Reprod 1996; 54:287–93.
  • McBean JH, Brumsted JR, Stirewalt WS. In vivo estrogen regulation of epidermal growth factor receptor in human endometrium. J Clin Endocrinol Metab 1997;82:1467–71.
  • Yarden RI, Lauber AH, El-Ashry D, Chrysogelos SA. Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells. Endocrinology 1996;July. p. 2739–47.
  • Ignar Trowbridge DM, Nelson KG, Bidwell MC, Curtis SW, Washburn TF, McLachlan JA, et al. Coupling of dual signaling pathways: epidermal growth factor action involves the estrogen receptor. Proc Natl Acad Sci USA 1992;89:4658–62.
  • Matsukawa Y, Marui N, Sakai T, Satomi Y, Yoshida M, Matsumoto K, et al. Genistein arrests cell cycle progression at G2-M. Cancer Res 1993;53:1328–31.
  • Wang C, Kurzer MS. Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors. Nutr Cancer 1998;31:90–100.
  • Peterson G, Barnes S. Genistein inhibits both estrogen- and growth factor- stimulated proliferation of human breast cancer cells. Cell Growth Diff 1996;7:1345–51.
  • Kumar V, Green S, Staub A, Chambon P. Localisation of the oestradiol-binding and putative DNA-binding domains of the human oestrogen receptor. EMBO J 1986;5:2231–6.
  • Bolander FF. Molecular endocrinology. San Diego (CA): Academic Press; 1989. p. 205–27.
  • Francavilla A, Ove P, Polimeno L, Sciascia C, Coetzee M, Pellici R, et al. Different response to epidermal growth factor of hepatocytes in cultures isolated from male or female rat liver. Gastroenterology 1987;93:597–605.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.